ArticleCancer chemotherapy and pharmacology2025

Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study.

Ching-Yuan Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.